Key result
Door-to-needle time ≤60 minutes linked to ~121% higher odds of good functional outcomes in ischemic stroke.
Why the study?
Timely reperfusion is critical for favorable acute ischemic stroke outcomes, but delays before and after hospital arrival remain common in India.
Does faster reperfusion (DTN ≤60 min and OTN ≤180 min) improve 90-day functional recovery in adults with acute ischemic stroke?
Observational (n=250)
No
Does faster reperfusion (DTN ≤60 min and OTN ≤180 min) improve 90-day functional recovery in adults with acute ischemic stroke?
Faster reperfusion times (door-to-needle ≤60 min and onset-to-needle ≤180 min) significantly improve the odds of good 90-day functional recovery in patients with acute ischemic stroke.
Answers are grounded in this paper and cite their sources.
Supports DTN ≤60 min targets in thrombolysis; hypothesis-generating, requires RCTs before practice change.
Objectives: Timely reperfusion is critical for favorable outcomes in acute ischemic stroke (AIS), yet delays before and after hospital arrival remain common in India. To assess pre-hospital delay, door-to-needle (DTN) time, and their independent association with 90-day functional outcomes in AIS patients receiving reperfusion therapy. Materials and Methods: A prospective observational study enrolled 250 consecutive adults with neuroimaging-confirmed AIS who received reperfusion therapy at a tertiary care center in Tamil Nadu between January 2023 and December 2024. Eligible patients received intravenous alteplase at 0.9 mg/kg (maximum 90 mg; 10% bolus followed by 60 min infusion) or, when used per institutional protocol, tenecteplase 0.25 mg/kg (maximum 25 mg) as a single bolus; patients with large-vessel occlusion were evaluated for bridging mechanical thrombectomy using standard imaging-based criteria, including DAWN/DEFUSE-3 selection principles for the extended window. The sample size was estimated using a single-proportion formula (anticipated favorable outcome 50%, 95% confidence level, 6.5% absolute precision), yielding 227 patients; after inflating by 10% for incomplete follow-up, the final target was 250. Functional outcome at 90 days was assessed using the modified Rankin Scale (mRS), and multivariable logistic regression was used to estimate adjusted odds ratios (AORs) with 95% confidence intervals (CIs). Results: Among 250 patients, 131 achieved a good 90-day functional outcome (mRS 0–2; 52.4%, 95% CI 46.2–58.5). Good outcome was more frequent with DTN time ≤60 min (66.7%, 95% CI 56.6–75.4) than with DTN >90 min (31.7%, 95% CI 21.6–44.0) and with onset-to-needle (OTN) time ≤180 min (70.0%, 95% CI 57.5–80.1) than with OTN >270 min (33.3%, 95% CI 24.5–43.6). In multivariable analysis, DTN ≤60 min (AOR 2.21, 95% CI 1.33–3.55; p = 0.002), OTN ≤180 min (AOR 1.88, 95% CI 1.07–3.21; p = 0.03), baseline National Institutes of Health Stroke Scale <10 (AOR 3.02, 95% CI 1.89–4.76; p < 0.001), age <65 years (AOR 1.72, 95% CI 1.01–2.94; p = 0.047), and urban residence (AOR 1.61, 95% CI 1.00–2.57; p = 0.048) independently predicted good recovery, whereas diabetes mellitus reduced the odds (AOR 0.64, 95% CI 0.42–0.98; p = 0.04). Conclusion: Faster reperfusion was associated with better 90-day functional recovery without a significant increase in hemorrhagic complications. Strengthening emergency medical services, promoting early presentation, and enforcing DTN benchmarks are essential to improve stroke outcomes.
No takes yet. Share an insight, caveat, or question.
Jena et al. (2026) conducted an observational in Acute ischemic stroke (n=250). Door-to-needle (DTN) time ≤60 min vs. Door-to-needle (DTN) time >60 min was evaluated on Good functional outcome (mRS 0-2) at 90 days (AOR 2.21, 95% CI 1.33-3.55, p=0.002). Door-to-needle time ≤60 minutes independently increased the odds of a good 90-day functional outcome by more than two-fold in patients with acute ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: